COMBINATION THERAPY FOR PROPHYLAXIS AND/OR TREATMENT OF BENIGN PROSTATIC HYPERPLASIA

摘要

The invention relates to a combination therapy for the prophylaxis and / or treatment of benign prostatic hyperplasia in warm-blooded animals susceptible to developing such disease. This therapy comprises administering a combination of at least two compounds selected from the group consisting of an activity inhibitor of 5alpha-reductase, with an anti-estrogen, for an activity aromatase inhibitor, with an inhibitor of dehydrogenase activity 17beta-hydroxysteroid and in some cases, an antiandrogen and / or an LHRH agonist. Pharmaceutical compositions used in such treatment and pharmaceutical kits containing such compositions are disclosed.